ITCI — Intra-Cellular Therapies Share News
0.000.00%
Last trade - 00:00- $14.04bn
- $13.04bn
- $680.85m
Intra-Cellular Therapies Inc reports results for the quarter ended December 31 - Earnings Summary
U.S. RESEARCH ROUNDUP-Apple, Caterpillar, Visa
Street View: New drug launches, ITCI deal to boost J&J's growth
J&J beats quarterly sales and profit estimates on cancer drug sales (updated)
J&J beats quarterly sales and profit estimates on cancer drug sales
U.S. RESEARCH ROUNDUP- Capital One Financial, Netflix, Regeneron Pharmaceuticals
J&J’s $15 bln depression deal eases pharma blues
Brokerages downgrade Intra-Cellular after J&J deal
U.S. RESEARCH ROUNDUP- BlackRock, Cencora, UnitedHealth
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Dexcom, Urban Outfitters, Kinder Morgan
J&J’s $15 bln depression deal eases pharma blues
Intra-Cellular hits record high on $14.6 billion buyout from J&J
Factbox: Drugmakers rush to sign deals on first day of industry conference
U.S. STOCKS ON THE MOVE-Moderna, Urban Outfitters, Kinder Morgan
U.S. STOCKS ON THE MOVE-Dexcom, American Eagle Outfitters, Essex Property
Brief: Intra-Cellular Therapies Upon Termination Of Deal, To Pay Johnson & Johnson Termination Fee Of $475.5 Million
U.S. STOCKS ON THE MOVE-Howard Hughes, Intra-Cellular Therapies, Lululemon
Brief: Johnson & Johnson To Acquire Intra-Cellular Therapies for $14.6 billion